Clinical trialNCT03130738CompletedPhase 2Interventional

Dose-Ranging Study for Miconazole Oil for Treatment of Otomycosis

SponsorHill Dermaceuticals, Inc.Enrollment65Otomycosis

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of the study is to evaluate the efficacy and safety of active treatment (miconazole oil) for 7 versus 14 days, and to compare 14 days of active treatment (miconazole oil) to inactive treatment (placebo) over a 14-day treatment duration, in subjects with fungal infection (otomycosis) of the external ear.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Jack Wazen, MD
Silverstein Institute
Principal Investigator
clinicaltrials.gov ↗
Kenneth Hodge, MD
Advanced ENT and Allergy
Principal Investigator
clinicaltrials.gov ↗
Kenneth S Maxwell, MD
Piedmont Ear, Nose and Throat Associates
Principal Investigator
clinicaltrials.gov ↗
Quyen T Nguyen, MD
UCSD
Principal Investigator
clinicaltrials.gov ↗
Rosario G Ramirez, MD
Hill Dermaceuticals, Inc.
Study Director
clinicaltrials.gov ↗
Woo Linda, MD
Head and Neck Surgery Specialists
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Head and Neck Surgery Specialist
Chula Vista, California, United States
University of California San Diego
La Jolla, California, United States
Ear Nose and Throat Associates of Southe Florida
Boynton Beach, Florida, United States
Silverstein Institute
Sarasota, Florida, United States
Advanced Ent and Allergy
Louisville, Kentucky, United States
Piedmont Ent Associates
Winston-Salem, North Carolina, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

14-Day Miconazole Oil14-Day Placebo - Oil Vehicle7-Day Miconazole Oil

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 20 Apr 2017
Primary completion: 6 Aug 2019
Completion: 6 Aug 2019
Last update posted: 5 Oct 2022
Registered enrollment: 65
Registry id: NCT03130738

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.